Fieldview Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mattel
MAT
|
+$4.96M |
| 2 |
Booking.com
BKNG
|
+$4.36M |
| 3 |
SGI
Somnigroup International
SGI
|
+$4.19M |
| 4 |
PVH
PVH
|
+$3.52M |
| 5 |
Kontoor Brands
KTB
|
+$3.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WesBanco
WSBC
|
+$3.45M |
| 2 |
Teradyne
TER
|
+$3.16M |
| 3 |
Biogen
BIIB
|
+$3.14M |
| 4 |
Broadstone Net Lease
BNL
|
+$2.8M |
| 5 |
National Health Investors
NHI
|
+$2.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 25.41% |
| 2 | Financials | 20.96% |
| 3 | Industrials | 12.52% |
| 4 | Technology | 11.18% |
| 5 | Healthcare | 7.72% |
Similar funds
Fieldview Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Fieldview Capital Management held 748 positions worth $351M, up 2.4% from $343M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Fieldview Capital Management withdrew a net $13.7M in Q2 2026, closing 241 positions and reducing 124 holdings. Its most notable exit was WesBanco, an estimated $3.45M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
Against the trend, Fieldview Capital Management opened a new position in Mattel worth $4.71M.
- Fieldview Capital Management's largest Q2 2026 buy was Mattel: 338,980 shares worth $4.71M.
- Fieldview Capital Management added most to Booking.com in Q2 2026, an estimated $4.36M increase.
- Fieldview Capital Management's biggest Q2 2026 reduction was Biogen, cutting an estimated $3.14M.
- Fieldview Capital Management fully exited WesBanco in Q2 2026, selling an estimated $3.45M.
- Fieldview Capital Management's ten largest holdings make up 12% of its $351M portfolio in Q2 2026.
- Fieldview Capital Management opened 280 new positions and closed 241 in Q2 2026.
- Fieldview Capital Management's portfolio value rose 2.4% quarter-over-quarter to $351M.
Based on Fieldview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.